NASDAQ: RGEN · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Repligen Corporation

How Repligen Corporation compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$10.7B

Price

$188.64

P/E

-906.0

EPS (TTM)

$-0.21

1-year return

27.0%

Dividend yield

0.0%

52-week range

$154.36–$192.23

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources